We are not currently engaged in, and we will not engage in, any substantive commercial business for an indefinite period. We intend to utilize cash derived from the proceeds of our IPO and the Private Placement, our capital stock, debt or a combination of these in effecting our Initial Business Combination. Although substantially all of the net proceeds of our IPO and the Private Placement are intended to be applied generally toward effecting an Initial Business Combination, the proceeds are not otherwise being designated for any more specific purposes. Accordingly, our investors do not currently have the opportunity to evaluate the specific merits or risks of any one or more business combinations. Our Initial Business Combination may involve the acquisition of, or merger with, a company which does not need substantial additional capital but which desires to establish a public trading market for its shares, while avoiding what it may deem to be adverse consequences of undertaking a public offering itself. These include time delays, significant expense, loss of voting control and compliance with various Federal and state securities laws. In the alternative, we may seek to consummate our Initial Business Combination with a company that may be financially unstable or in its early stages of development or growth. While we may seek to effect simultaneous business combinations with more than one target business, we will probably have the ability, as a result of our limited resources, to effect only a single business combination.
Company profile
Ticker
MWRX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
MedWorth Acquisition Corp.
SEC CIK
Corporate docs
IRS number
461970047
Latest filings (excl ownership)
15-12B
Securities registration termination
9 Jan 15
RW
Registration withdrawal request
7 Jan 15
25-NSE
Exchange delisting
30 Dec 14
8-K
Other Events
29 Dec 14
425
Business combination disclosure
16 Dec 14
8-K
MergeWorthRx Corp. Announces Offer by its Sponsors to Transfer Founder Shares
16 Dec 14
424B3
Prospectus supplement
12 Dec 14
EFFECT
Notice of effectiveness
12 Dec 14
Latest ownership filings